LIAISON QUICK DETECT
DEAD

Serial Number

97115815

Owner

DIASORIN S.P.A.

Attorney

Jeffrey B. Sladkus, Esq.

Filing Date

Nov 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LIAISON QUICK DETECT Trademark

Serial Number: 97115815

LIAISON QUICK DETECT is a trademark filed by DIASORIN S.P.A. on November 9, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

DIASORIN S.P.A. (15 trademarks)

VIA CRESCENTINO SNC
SALUGGIA, VERCELLI 13040 , IT

Entity Type: 09

DiaSorin Inc. (6 trademarks)

1951 Northwestern Avenue
Stillwater, MN 55082

Entity Type: 03

Trademark Details

Filing Date

November 9, 2021

Registration Date

Not Registered

Goods & Services

Downloadable computer software mobile applications for use in diagnosing individuals; downloadable computer software for medical diagnostics and for use to operate diagnostic apparatuses not for medical purpose; downloadable portable and cloud-connected POC (Point of care) immunodiagnostic software platform for diagnosing individuals; Downloadable computer software and hardware for the design, creation and control of tools for medical diagnostics, data-processing software, apparatus, equipment, hardware and computers for diagnostics; data storage, processing and transmission apparatus for diagnostic purpose, namely, blank tapes for storage of computer data; electronic book readers for diagnostic purpose; PC tablets used for test and diagnostic purpose; Video monitors; structural parts and fittings for the aforementioned goods where applicable, all applied in the diagnostic field; Testing apparatus not for medical purposes, namely, apparatus for testing liquids and solids; testing machines and instruments for diagnostic purpose, other than for medical use, namely, apparatus for testing liquids and solids, composed of PC tablets and optical reader; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

Diagnostic testing apparatus for medical purposes for testing biomarkers and other biomolecules; medical diagnostic apparatus for medical purposes; tools for medical diagnostics, namely, medical diagnostic apparatus for testing for viruses and infection diseases; medical devices for diagnosing viruses; medical testing equipment, namely, medical device for detecting antibodies against SARS-CoV-2; medical apparatus for use in medical analysis for analyzing bacteria; Electronic analyzers for bacterial identification for medical purposes; apparatus for taking blood samples; apparatus for taking body fluid samples; Point of Care (POC) diagnostic, examination, and monitoring equipment, namely, respiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes; diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; medical diagnostic apparatus for the identification of antigens to diagnose Covid-19 via nasal swab; diagnostic apparatus for the identification of virus and infectious diseases; radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; medical diagnostic apparatus for testing for viruses; apparatus for DNA and RNA testing for medical purposes; Syringes for injections; syringes for medical purposes; hypodermic syringes; extraction medical syringes; disposable hypodermic syringes for medical use; medical syringe needles; needles for medical purposes; medical micro-needling devices

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 10, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 7, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 7, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 14, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 29, 2022 GNFN
FINAL REFUSAL E-MAILED
Nov 29, 2022 GNFR
FINAL REFUSAL WRITTEN
Nov 29, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2022 CRFA
ASSIGNED TO LIE
Oct 26, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2022 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2021 NWOS
NEW APPLICATION ENTERED
Nov 12, 2021 NWAP